Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

25 May 2017 07:00

RNS Number : 1609G
Huntsworth PLC
25 May 2017
 

 

Huntsworth

Trading update

 

Huntsworth plc, the healthcare communications and public relations group, is today issuing the following trading update for the four months to 30 April 2017.

 

· Group's full year results to be ahead of current consensus

· Strong trading at Huntsworth Health and Red

· Grayling trading in line with management expectations helped by UK agency returning to profit

 

Trading

 

The Group traded well through the first four months of the year, led again by strong growth at Huntsworth Health. On a like for like basis Huntsworth Health's revenues increased by over 10%, with good margin performance despite ongoing investment in talent and further diversification in two of the agencies. All of Huntsworth Health's main agencies grew in the period, led by the two largest - Evoke and Apothecom - which together account for circa 80% of divisional revenue.

 

Grayling's UK business returned to profitability in the period which means that, together with its European businesses, a large part of Grayling (representing circa 70% of annual divisional revenues) is now profitable. The US and META regions, however, remain challenging. Although we expect a decline in Grayling's like for like revenues this year, the division is trading in line with management's expectations.

 

Red has performed strongly in the period with revenues up by over 10%, with a number of new client wins. Some client churn is expected in the second half of the year which will dampen the overall annual growth rate.

 

Citigate Dewe Rogerson has experienced a mixed trading period with revenues down 2% on a like for like basis. Operations in the Netherlands, Singapore and Hong Kong have performed well, but slower transactional markets in the UK and mainland China have impacted overall revenue growth and profitability and will likely weigh on the business further during the year.

 

 

Financial Position

 

The Group remains in a strong financial position, operating well within its £70m facility. Net debt at 19 May 2017 was c. £31m, in line with management expectations.

 

 

Outlook

 

As a result of the stronger growth at Health and Red along with improved prospects at Grayling, we now expect the Group's full year results to be ahead of current consensus*.

 

The Group remains focused on driving operating profit by concentrating resources on its faster growing agencies and actively managing those underperforming ones. The Board is confident of continued progress through the remainder of 2017.

 

 

*Midpoint of consensus range for Headline PBT is £19.3m

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Georgia Colkin

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGPAUPMGQC
Date   Source Headline
26th Jul 20177:00 amRNSInterim Results for the six months to 30 June 2017
11th Jul 20172:28 pmRNSHolding(s) in Company
6th Jul 20172:04 pmRNSDirector/PDMR Shareholding
5th Jul 20177:00 amRNSAdditional Listing
4th Jul 20173:33 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSAcquisition of The Creative Engagement Group
29th Jun 20175:53 pmRNSHolding(s) in Company
29th Jun 201712:33 pmRNSDisposal by BlueFocus
22nd Jun 20179:00 amRNSNotice of Interim Results
14th Jun 201711:27 amRNSHolding(s) in Company
2nd Jun 201711:07 amRNSScrip Dividend Alternative
25th May 20172:22 pmRNSResults of Annual General Meeting
25th May 20177:00 amRNSTrading Update
9th May 20175:38 pmRNSHolding(s) in Company
9th May 20179:13 amRNSDirector Declaration
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension
28th Apr 20174:47 pmRNSHolding(s) in Company
28th Apr 201710:48 amRNSHolding(s) in Company
27th Apr 20178:59 amRNSDisposal and lock-up arrangement
25th Apr 20179:30 amRNSNotice of AGM
22nd Mar 201710:30 amRNSDirector/PDMR Shareholding
21st Mar 20177:00 amRNSPreliminary results year ended 31 December 2016
16th Feb 20177:00 amRNSTrading update for year ending 31 December 2016
3rd Feb 20173:27 pmRNSHolding(s) in Company
27th Jan 20174:08 pmRNSNotice of Result & Change to Audit Committee Chair
16th Dec 20164:49 pmRNSDirector/PDMR Shareholding
16th Dec 20163:27 pmRNSHolding(s) in Company
16th Dec 20162:18 pmRNSChange of Auditor
14th Dec 20164:00 pmRNSDirector/PDMR Shareholding
13th Dec 201611:15 amRNSDirector/PDMR Shareholding
9th Dec 20165:10 pmRNSDirector/PDMR Shareholding
6th Dec 20164:21 pmRNSChange of Auditor
6th Dec 20168:18 amRNSHolding(s) in Company
2nd Dec 201612:59 pmRNSBlock listing Interim Review
1st Dec 20161:05 pmRNSTotal Voting Rights
10th Nov 20164:17 pmRNSDirector/PDMR Shareholding
9th Nov 20164:10 pmRNSDirector/PDMR Shareholding
3rd Nov 201610:42 amRNSAdditional Listing
6th Oct 20162:45 pmRNSScrip Dividend Alternative
15th Sep 20162:22 pmRNSHolding(s) in Company
12th Sep 20164:17 pmRNSDirector/PDMR Shareholding
4th Aug 20165:45 pmRNSHolding(s) in Company
4th Aug 201611:28 amRNSHolding(s) in Company
3rd Aug 20164:43 pmRNSHolding(s) in Company
3rd Aug 20162:19 pmRNSHolding(s) in Company
3rd Aug 20162:10 pmRNSHolding(s) in Company
2nd Aug 20167:00 amRNSTotal Voting Rights
26th Jul 20166:00 pmRNSDirector/PDMR Shareholding
26th Jul 20167:00 amRNSInterim results for the six months to 30 June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.